CMV seropositivity was assessed by the detection of IgG antibodies to CMV late antigen. All patients and 31 donors (84%) were seropositive for CMV. CMV antigenemia was monitored weekly after ...
SAN DIEGO--(BUSINESS WIRE)--BioLegend announces that it has licensed from Sanquin Blood Supply Foundation a novel technology to study antigen-specific T cells. Through a collaborative effort, ...
An immunological test known as a “tetramer assay” can detect and quantify the T cells in a blood sample that are able to recognize a specific antigen, such as a viral protein. Making the molecular ...
New immunotherapies such as adoptive cell transfer, TCR gene therapy and peptide vaccination have the potential to cure human disease in the future. Rosenberg and his colleagues have reported the ...
An immunological test known as a “tetramer assay” can detect and quantify the T cells in a blood sample that are able to recognize a specific antigen, such as a viral protein. Making the molecular ...
The cost of making a Phycoerythrin conjugated tetramer is $800. The most expensive reagents are the biotin ligase (BirA from Avidity, LLC) and the PE-conjugated streptavidin (Prozyme). On occasion, it ...
Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma Purpose: To measure the CD8 + T-cell response to a melanoma peptide ...
In preclinical proteomics, speed and accuracy are paramount. Increasingly, scientists must capture more data in less time while consuming minimal sample. Given the throughputs required for efficient ...
BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ: CLVS) announced that nonclinical data describing the expression of fibroblast activating protein (FAP) in a variety of solid tumor types ...
MHC-Peptide Tetramers play a crucial role in immunological research, particularly in cancer immunotherapy, vaccine development, and infectious disease studies. LOS ...
MHC-Peptide Tetramers play a crucial role in immunological research, particularly in cancer immunotherapy, vaccine development, and infectious disease studies. LOS ANGELES, CA, UNITED STATES, March 3, ...